Age-and dose-specific anticonvulsant action of bumetanide in immature rats

Physiological Research

Volumn 58, Issue 6, 2009, Pages 927-930

  Mares, P ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Chloride transporter; GABA; Ontogeny; Pentylenetetrazol; Rat

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; BUMETANIDE; LOOP DIURETIC AGENT; PENTETRAZOLE; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 1 PROTEIN; SODIUM-POTASSIUM-CHLORIDE COTRANSPORTER 1 PROTEIN;

AGE; AGING; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GRAND MAL EPILEPSY; MALE; METABOLISM; RAT; REACTION TIME; WISTAR RAT;

AGE FACTORS; AGING; ANIMALS; ANTICONVULSANTS; BUMETANIDE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TONIC-CLONIC; GAMMA-AMINOBUTYRIC ACID; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; REACTION TIME; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS;

EID: 77449128136     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. BEN-ARI Y: Excitatory actions of GABA during development: the nature of the nurture. Nature Rev Neurosci 3: 728-739, 2002.
2. BROWNING RA, NELSON DK: Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulation. Life Sci 37: 2205-2211, 1985.
3. DZHALA V, TALOS DM, SDRULLA DA, BRUMBACK AC, MATHEWS GC, BENKE TA, DELPIRE E, JENSEN FE, STALEY KJ: NKCC1 transporter facilitates seizures in the developing brain. Nature Medicine 11: 1205-1213, 2005.
4. DZHALA V, BRUMBACK AC, STALEY KJ: Bumetanide enhances phenobarbital efficacy in a neonatal seizure model. Ann Neurol 63: 222-235, 2007.
5. EADIE SK, CHRISTENSEN ML: The clinical pharmacology of loop diuretics in the pediatric patient. Pediat Nephrol 12: 603-616, 1998.
6. HUBERFELD G, WITTNER L, CLEMENCEAU S, BAULAC M, KAILA K, MILES R, RIVERA C: Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27: 9866-9873, 2007.
7. KHALILOV I, HOLMES GL, BEN-ARI Y: In vitro formation of a secondary epileptogenic mirror focus by interhippocampal propagation of seizures. Nature Neurosci 6: 1079-1083, 2003.
8. KILB W, SINNING A, LUHMANN HJ: Model-specific effects of bumetanide on epileptiform activity in the in vitro intact hippocampus of the newborn mouse. Neuropharmacology 53: 524-533, 2007.
9. MAREŠ P: Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen. Physiol Res 57: 789-792, 2008a.
10. MAREŠ P: AMN 082, an agonist of mGluR7, exhibits mixed anti and proconvulsant effects in developing rats. Physiol Res 57: 969-972, 2008b.
11. MAZARATI A, SHIN D, SANKAR R: Bumetanide inhibits rapid kindling in neonatal rats. Epilepsia 50: 2117-2122, 2009.
12. MÖHLER H, FRITSCHY JM, VOGT K, CRESTANI F, RUDOLPH U: Pathophysiology and pharmacology of GABA(A) receptors. Handb Exp Pharmacol 169: 225-247, 2005.
13. NARDOU R, BEN-ARI Y, KHALILOV I: Bumetanide, an NKCC1 antagonist, does not prevent formation of epileptogenic focus but blocks epileptic focus seizures in immature rat hippocampus. J Neurophysiol 101: 2878-2888, 2009.
14. PAYNE JA, RIVERA C, VOIPIO J, KAILA K: Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 26: 199-206, 2003.
15. POHL M, MAREŠ P: Flunarizine influences metrazol-induced seizures in developing rats. Epilepsy Res 1: 302-305, 1987.
16. SCHWARTZKROIN PA, BARABAN SC, HOCHMAN DW: Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res 32: 275-285, 1998.
17. VELÍŠEK L, KUBOVÁ H, POHL M, STANKOVÁ L, MAREŠ P, SCHICKEROVÁ R: Pentylenetetrazol-induced seizures in rats: an ontogenetic study. Naunyn-Schmiedeberg's Arch Pharmacol 346: 588-591, 1992.